Nuzenio

Dupixent

Dupixent news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 11:40:54 GMTSanofi asked to change Dupixent ads after Galderma challenge - fiercepharma.com
Wed, 05 Aug 2026 17:00:00 GMTNational Advertising Division Finds Certain DUPIXENT Claims - GlobeNewswire
Wed, 05 Aug 2026 17:00:00 GMTNational Advertising Division Finds Certain DUPIXENT Claims Supported; Recommends Sanofi Modify or Discontinue Other Claims - Yahoo Finance Singapore
Wed, 05 Aug 2026 10:58:58 GMTAttovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO - Fierce Biotech
Sun, 02 Aug 2026 21:22:29 GMTRegeneron: Dupixent Sales Reach $6 Billion As Sanofi Repayment Unlocks Profit And Cash Flow Inflection - Pulse 2.0
Thu, 30 Jul 2026 19:41:50 GMTSanofi drug pipeline worries, Dupixent dependence shake shares - Reuters

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Dupixent.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.